Before my previous post I quickly searched PR's et
Post# of 9122
advisory board wasnt created until 2009
I was under impression Michele had been there only a relatively short time -linkedin would answer that - i just havent looked at it again
Portions of applicable updates are below -I know u Sierra probably know these things but some dont
The corporation has notified NanoLogix it intends to use approximately 12,000 units of NanoLogix detection technology for a project beginning in July 2012. This marks the first large sale of NanoLogix technology.
I think Michele was hired after the following but due to above cant find -and havent looked at her linkedin again:
May 21, 2012: Updates to Cleanroom Manufacturing Operation
NanoLogix has recently completed major changes and updates to the cleanroom manufacturing operation. These enhancements have been implemented to optimize product quality and the manufacturing process. A computerized, state of the art, environmental monitoring system designed by LIGHTHOUSE Worldwide Solutions has been installed and is in operation. This system continuously monitors air quality, temperature, humidity, and air pressure on a real-time basis. Our cleanroom air filtration system has been re-designed to maximize the quality of the air within the space. The air filtration system has been upgraded to include 10 high-quality AIRGUARD filters, thus enabling our manufacturing space to operate at a solid ISO 6 level in a static mode as described within ISO 14644-1 Cleanroom Standards.
NanoLogix Clean Room
May 14, 2012: Data Collection Completed for Group B Strep Clinical Study
........
The University of Texas Health Science Center has recently revised its regulations for staff involvement with private companies. In order to comply with this change, Drs. Sebastian Faro and Alan Katz have resigned from the NanoLogix Science Advisory Board. Both Dr. Faro and Dr. Katz will continue to participate in research involving NanoLogix technology.
February 9, 2012
Over the past year, major developments at NanoLogix have drawn the attention of food processors, medical and veterinary facilities, universities, major diagnostic kit producers, government agencies, large and small clinics and hospitals, and various labs. Interest in our products continues to grow among both domestic and international entities.
The comprehensive operations summary of 2011, which covers technology advances, partnership collaborations, preparations for FDA approvals, media coverage, financial information and the company’s new R&D laboratory.
August 25, 2010: New Patent Granted
The company has been issued U.S. patent #7,781,159 for its invention of a method and device for the rapid detection, enumeration and identification of microorganisms. This is one of two foundational patents granted this year for our BioNano technologies.
June 30, 2010: NanoLogix has filed and received medical device registration approval from the U.S. FDA for their BNP™ BNF™ and BNC™ test kits. Registration number: 3005553828.
June 24, 2010: The Company has received the remaining 10 machines ordered from New Brunswick Scientific. 'NBS' personnel will be in-house June 29 to complete setup and inspection of the equipment.
Copyright 2011 Nano
May 20, 2010: Negotiations to purchase corporate headquarters
May 12, 2010: NanoLogix has received and installed the first two machines of the twelve ordered from New Brunswick Scientific. We anticipate the balance of the equipment ordered to arrive in May or June. This brings the total machines installed in the production clean room to six, equaling three complete workstations.
April 23, 2010: This week the company ordered new equipment from New Brunswick Scientific. This order is for six MP-1000 Automated Plate Pourers and six MM9 MediaMatic Sterilizers. This equipment will add six workstations to the existing Hubbard, Ohio cleanroom production facility.
April 9, 2010:The company announces that it is adding two microbiologists and an additional lab tech to their Research and Development facility in Cincinnati at Bio/Start. NanoLogix is also moving their current R&D to larger labs within the Bio/Start facility in order to accommodate up to eight research personnel for the foreseeable future.
March 26, 2010: The company would like to announce that it has completed construction of its cleanroom production facility. Completion was delayed from the original date by the decision to add an additional cleanroom thereby increasing the potential work stations from thirty-four to fifty-six. Over the next two weeks the company will be performing extensive cleaning of the facility, test runs on the two existing work stations, system tests, and preparing for the installation of additional New Brunswick Scientific equipment currently under order.